UB Paderborn / Katalog / Suche / in CDI

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

European heart journal, 2020-06, Vol.41 (24), p.2313-2330

2020

Link zum Volltext

Verfügbarkeit prüfen

Statin use and non-alcoholic steatohepatitis in at risk individuals

Journal of hepatology, 2015-09, Vol.63 (3), p.705-712

2015

Link zum Volltext

Verfügbarkeit prüfen

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

Gastroenterology (New York, N.Y. 1943), 2016-05, Vol.150 (5), p.1219-1230.e6

2016

Link zum Volltext

Verfügbarkeit prüfen

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

Clinical chemistry (Baltimore, Md.), 2018-07, Vol.64 (7), p.1006-1033

2018

Link zum Volltext

Verfügbarkeit prüfen

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

European heart journal, 2017-08, Vol.38 (29), p.2245-2255

2017

Link zum Volltext

Verfügbarkeit prüfen

Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages

Atherosclerosis, 2009-02, Vol.202 (2), p.382-393

2009

Link zum Volltext

Verfügbarkeit prüfen

Patatin-like phospholipase domain-containing 3 ( PNPLA3 ) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

Journal of hepatology, 2012-12, Vol.57 (6), p.1276-1282

2012

Link zum Volltext

Verfügbarkeit prüfen

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

Nature (London), 2002-06, Vol.417 (6890), p.750-754

2002

Link zum Volltext

Verfügbarkeit prüfen

Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy

Current cardiology reports, 2013-09, Vol.15 (9), p.397, Article 397

2013

Link zum Volltext

Verfügbarkeit prüfen

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Diabetes (New York, N.Y.), 2009-09, Vol.58 (9), p.2018-2026

2009

Link zum Volltext

Verfügbarkeit prüfen

Arachidonate 15-lipoxygenase type B knockdown leads to reduced lipid accumulation and inflammation in atherosclerosis

PloS one, 2012-08, Vol.7 (8), p.e43142-e43142

2012

Link zum Volltext

Verfügbarkeit prüfen

ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo

Atherosclerosis, 2006-10, Vol.188 (2), p.323-330

2006

Link zum Volltext

Verfügbarkeit prüfen

In Memoriam: Sven-Olof Olofsson (1947-2011)1

Journal of lipid research, 2012-10, Vol.53 (10), p.2015-2016

2012

Link zum Volltext

Verfügbarkeit prüfen

Elderly benefit from lower LDL-cholesterol

Läkartidningen, 2021-03, Vol.118

Wiklund, Olov

2021

Link zum Volltext

Verfügbarkeit prüfen

Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia

Journal of clinical lipidology, 2016-07, Vol.10 (4), p.816-823

2016

Link zum Volltext

Verfügbarkeit prüfen

Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease

Vascular health and risk management, 2007, Vol.3 (4), p.491-502

2007

Link zum Volltext

Verfügbarkeit prüfen

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

Journal of the American College of Cardiology, 2008-12, Vol.52 (25), p.2190-2197

2008

Link zum Volltext

Verfügbarkeit prüfen

In Memoriam: German Camejo (1936–2021)

Atherosclerosis, 2022-01, Vol.341, p.80-81

2022

Link zum Volltext

Verfügbarkeit prüfen

The new joint EAS/ESC guidelines for the management of dyslipidaemias

Atherosclerosis, 2011-07, Vol.217 (1), p.1-1

2011

Link zum Volltext

Verfügbarkeit prüfen

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

European heart journal, 2014-08, Vol.35 (32), p.2146-2157

2014

Link zum Volltext

Verfügbarkeit prüfen

Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages

Atherosclerosis, 2006-03, Vol.185 (1), p.32-38

2006

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Statin use and non-alcoholic steatohepatitis in at risk individuals

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages

Patatin-like phospholipase domain-containing 3 ( PNPLA3 ) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy

ApoCIII-Enriched LDL in Type 2 Diabetes Displays Altered Lipid Composition, Increased Susceptibility for Sphingomyelinase, and Increased Binding to Biglycan

Arachidonate 15-lipoxygenase type B knockdown leads to reduced lipid accumulation and inflammation in atherosclerosis

ATP depletion in macrophages in the core of advanced rabbit atherosclerotic plaques in vivo

In Memoriam: Sven-Olof Olofsson (1947-2011)1

Elderly benefit from lower LDL-cholesterol

Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia

Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease

Long-Term Effects of Fenofibrate on Carotid Intima-Media Thickness and Augmentation Index in Subjects With Type 2 Diabetes Mellitus

In Memoriam: German Camejo (1936–2021)

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

The new joint EAS/ESC guidelines for the management of dyslipidaemias

Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages

Suchergebnisse filtern